Suvorexant (Belsomra(®) Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey

BACKGROUND: We report on the results of a Japanese postmarketing drug-use survey of suvorexant (Belsomra(®)) tablets. METHODS: A survey with a ≤ 6-month observation period after the start of administration was conducted, targeting insomnia patients who were treated with suvorexant for the first time...

Descripción completa

Detalles Bibliográficos
Autores principales: Asai, Yuko, Sano, Hideki, Miyazaki, Makoto, Iwakura, Mika, Maeda, Yoshikazu, Hara, Mitsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380968/
https://www.ncbi.nlm.nih.gov/pubmed/30552562
http://dx.doi.org/10.1007/s40268-018-0256-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380968/
https://www.ncbi.nlm.nih.gov/pubmed/30552562
http://dx.doi.org/10.1007/s40268-018-0256-6

Ejemplares similares